We aim to be recognised as a world-class centre of excellence for research into antimicrobials and antimicrobial resistance. Medicine is at a critical juncture: the rise of resistant microbes raises the prospect of a world without antibiotics, where simple infections and routine medical interventions are once again fraught with risk. We urgently need to develop new drugs, vaccines, biologicals and biomaterials to treat or prevent infection as well as better diagnostics.
This requires expertise in bacteriology, parasitology, mycology, virology and beyond; our collaborations take in a diverse range of fields, including chemistry, maths and computer sciences.
This successful multidisciplinary approach has been recognised by the Engineering and Physical Sciences Research Council (EPSRC), which granted a Wellcome Trust doctoral training programme in antimicrobials and antimicrobial resistance, joint with the University of Birmingham. EPSRC also funded a two-year project October 2015-October 2017, Bridging the Gaps: Systems-level approaches to antimicrobial resistance, to encourage cross-disciplinary activity.
The creation of a world-class centre for antimicrobial research will develop novel ways of treating and preventing infection. The University of Nottingham will also be at the forefront of training a new generation of research scientists to lead advances in the fight against antimicrobial resistance.
To tackle the threat of antibiotic resistance requires a coordinated multidisciplinary approach and sustained financial investment. The Wellcome Trust’s Strategic Plan 2010-20 identifies combating infectious disease as one its research challenges and the Medical Research Council is leading a cross-disciplinary initiative to identify funding targets in the fight against antimicrobial resistance.
The University of Nottingham is well-placed to attract investment thanks to the depth of our multidisciplinary expertise and a strategic response to this global challenge.
Research Centres, Groups and Institutes